Document Detail

Long-term continuous intraperitoneal insulin infusion with an implanted remote-controlled insulin infusion device.
MedLine Citation:
PMID:  7308587     Owner:  NLM     Status:  MEDLINE    
This is a report of the implantation and first 100-day operation using a remote-controlled programmable insulin infusion device in an insulin-dependent diabetic. To prevent insulin aggregation, a special surface-active polymer developed by Hoechst AG, Frankfurt, was used as an additive. Implantation was completed on April 8, 1981, and good metabolic control was reached immediately and has continued to date (July 1981), with this unit providing the only source of insulin. There have been no hypoglycemic attacks. Patient acceptance is very good. The Siemens unit, PFA 01 (external) and DFA 01 (implanted) has proved reliable and precise.
K Irsigler; H Kritz; G Hagmüller; M Franetzki; K Prestele; H Thurow; K Geisen
Related Documents :
14716077 - Volume kinetic analysis of fluid shifts accompanying intravenous infusions of glucose s...
20920437 - Guidelines for insulin dosing in continuous subcutaneous insulin infusion using new for...
1975987 - Thermogenic effect of thyroid hormones: interactions with epinephrine and insulin.
9203437 - Stability of insulin lispro in insulin infusion systems.
6373457 - C-peptide as a measure of the secretion and hepatic extraction of insulin. pitfalls and...
19530957 - Maternal serum adiponectin multimers in gestational diabetes.
Publication Detail:
Type:  Case Reports; Comparative Study; Journal Article    
Journal Detail:
Title:  Diabetes     Volume:  30     ISSN:  0012-1797     ISO Abbreviation:  Diabetes     Publication Date:  1981 Dec 
Date Detail:
Created Date:  1982-02-25     Completed Date:  1982-02-25     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0372763     Medline TA:  Diabetes     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1072-5     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Glucose / analysis
Hemoglobin A / analysis
Infusions, Parenteral
Insulin Infusion Systems*
Middle Aged
Surface-Active Agents
Reg. No./Substance:
0/Blood Glucose; 0/Surface-Active Agents; 9034-51-9/Hemoglobin A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  HLA and psoriasis in the Chinese.
Next Document:  The diagnosis of postprandial hypoglycemia.